生物信息学分析:COL1A1可能是幽门螺旋杆菌通过细胞毒素相关蛋白A参与胃腺癌进程的关键靶点
Bioinformatics Analysis: COL1A1 May Be a Key Target for Helicobacter Pylori to Participate in the Process of Gastric Adenocarcinoma through Cytotoxin-Associated Protein A
DOI: 10.12677/acm.2025.1561860, PDF,   
作者: 阚 笑:青岛大学基础医学院病原微生物学系,山东 青岛;青岛市中医医院(青岛大学附属青岛市海慈医院)检验科,山东 青岛;王 云:青岛大学基础医学院病原微生物学系,山东 青岛;宋晓萍*:青岛市中医医院(青岛大学附属青岛市海慈医院)检验科,山东 青岛
关键词: 胃腺癌幽门螺旋杆菌幽门螺杆菌细胞毒素相关蛋白ACOL1A1Gastric Adenocarcinoma Helicobacter Pylori Helicobacter Pylori Cytotoxin-Associated Protein A COL1A1
摘要: 目的:幽门螺杆菌细胞毒素相关蛋白A是一种已知的可诱导胃癌发展的重要毒力因子。本研究旨在通过生物信息学进一步确定具体在这一过程中发挥作用的生物学靶点。材料方法:首先,从基因表达综合数据库中筛选mRNA表达谱数据集GSE29998,并借助已有的研究成果,使用R软件(4.0.0版)分析幽门螺旋杆菌通过细胞毒素相关蛋白A参与胃腺癌进程的潜在差异表达基因,再借助富集分析进一步阐述其意义。并最终根据蛋白质互作网络的hub基因的排名,筛选出可能的潜在靶向基因。结果:我们通过差异性分析确定了540个可能的与胃腺癌相关的潜在差异基因。再结合陈等人的研究成果所提供的基因数据库,我们进一步确认18个与潜在的幽门螺杆菌细胞毒素相关蛋白A相关的胃腺癌差异表达基因。蛋白质–蛋白质相互作用网络提示只有COL1A1处于枢纽位置。因此我们认定COL1A1是与幽门螺杆菌细胞毒素相关蛋白A相关的胃腺癌差异表达基因。结论:我们的研究鉴定了在胃腺癌中18个潜在的幽门螺杆菌细胞毒素相关蛋白A相关的差异表达基因。幽门螺杆菌细胞毒素相关蛋白A可能借助COL1A1参与胃腺癌的发生发展过程中。本研究结果首次借助细胞实验相关数据筛选出临床样本中幽门螺杆菌可能影响胃腺癌发生的潜在生物学靶点,这可能有助于我们进一步理解这一疾病。
Abstract: Introduction: Helicobacter pylori cytotoxin-associated protein A is an important virulence factor known to induce the development of gastric cancer. This research aims to further determine the specific biological targets that play a role in this process through bioinformatics. Material method: Firstly, the mRNA expression profile dataset GSE29998 was screened from the comprehensive database of gene expression. With the help of existing research results, the potential differentially expressed genes of Helicobacter pylori involved in the process of gastric adenocarcinoma through cytotoxin-associated protein A were analyzed using R software (version 4.0.0), and its significance was further elaborated with the help of enrichment analysis. And finally, based on the ranking of hub genes in the protein-protein interaction network, possible potential targeted genes are screened out. Result: Through differential analysis, we identified 540 possible potentials differentially expressed genes related to gastric adenocarcinoma. Combined with the gene database provided by the research results of Chen et al., we further confirmed 18 differentially expressed genes of gastric adenocarcinoma related to the potential Helicobacter pylori cytotoxin-associated protein A. The protein-protein interaction network suggests that only COL1A1 is in the hub position. Therefore, we determined that COL1A1 is A differentially expressed gene in gastric adenocarcinoma associated with Helicobacter pylori cytotoxin-associated protein A. Conclusion: Our research identified 18 potentials differentially expressed genes related to Helicobacter pylori cytotoxin-associated protein A in gastric adenocarcinoma. Helicobacter pylori cytotoxin-associated protein A may be involved in the occurrence and development of gastric adenocarcinoma with the help of COL1A1. The results of this study are the first to screen out potential biological targets that Helicobacter pylori may affect the occurrence of gastric adenocarcinoma in clinical samples with the help of relevant data from cell experiments, which may help us further understand this disease.
文章引用:阚笑, 王云, 宋晓萍. 生物信息学分析:COL1A1可能是幽门螺旋杆菌通过细胞毒素相关蛋白A参与胃腺癌进程的关键靶点[J]. 临床医学进展, 2025, 15(6): 1356-1367. https://doi.org/10.12677/acm.2025.1561860

参考文献

[1] Park, J.Y., Forman, D., Waskito, L.A., Yamaoka, Y. and Crabtree, J.E. (2018) Epidemiology of Helicobacter pylori and CagA-Positive Infections and Global Variations in Gastric Cancer. Toxins, 10, Article No. 163. [Google Scholar] [CrossRef] [PubMed]
[2] Piazuelo, M.B., Epplein, M. and Correa, P. (2010) Gastric Cancer: An Infectious Disease. Infectious Disease Clinics of North America, 24, 853-869. [Google Scholar] [CrossRef] [PubMed]
[3] Joshi, S.S. and Badgwell, B.D. (2021) Current Treatment and Recent Progress in Gastric Cancer. CA: A Cancer Journal for Clinicians, 71, 264-279. [Google Scholar] [CrossRef] [PubMed]
[4] Schistosomes (1994) Liver Flukes and Helicobacter pylori. IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Vol. 61, 1-241.
[5] Helicobacter and Cancer Collaborative Group (2001) Gastric Cancer and Helicobacter pylori: A Combined Analysis of 12 Case Control Studies Nested within Prospective Cohorts. Gut, 49, 347-353. [Google Scholar] [CrossRef] [PubMed]
[6] Kamangar, F., Dawsey, S.M., Blaser, M.J., Perez-Perez, G.I., Pietinen, P., Newschaffer, C.J., et al. (2006) Opposing Risks of Gastric Cardia and Noncardia Gastric Adenocarcinomas Associated with Helicobacter pylori Seropositivity. JNCI: Journal of the National Cancer Institute, 98, 1445-1452. [Google Scholar] [CrossRef] [PubMed]
[7] Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., et al. (2001) Helicobacter pylori Infection and the Development of Gastric Cancer. New England Journal of Medicine, 345, 784-789. [Google Scholar] [CrossRef] [PubMed]
[8] El-Omar, E.M., Carrington, M., Chow, W., McColl, K.E.L., Bream, J.H., Young, H.A., et al. (2000) Interleukin-1 Polymorphisms Associated with Increased Risk of Gastric Cancer. Nature, 404, 398-402. [Google Scholar] [CrossRef] [PubMed]
[9] El-Omar, E.M., Carrington, M., Chow, W., McColl, K.E.L., Bream, J.H., Young, H.A., et al. (2001) Correction: The Role of Interleukin-1 Polymorphisms in the Pathogenesis of Gastric Cancer. Nature, 412, 99. [Google Scholar] [CrossRef] [PubMed]
[10] Crabtree, J.E., Taylor, J.D., Heatley, R.V., Shallcross, T.M., Rathbone, B.J., Wyatt, J.I., et al. (1991) Mucosal IgA Recognition of Helicobacter pylori 120 Kda Protein, Peptic Ulceration, and Gastric Pathology. The Lancet, 338, 332-335. [Google Scholar] [CrossRef] [PubMed]
[11] Ohnishi, N., Yuasa, H., Tanaka, S., Sawa, H., Miura, M., Matsui, A., et al. (2008) Transgenic Expression of Helicobacter pylori CagA Induces Gastrointestinal and Hematopoietic Neoplasms in Mouse. Proceedings of the National Academy of Sciences, 105, 1003-1008. [Google Scholar] [CrossRef] [PubMed]
[12] Nishikawa, H. and Hatakeyama, M. (2017) Sequence Polymorphism and Intrinsic Structural Disorder as Related to Pathobiological Performance of the Helicobacter pylori CagA Oncoprotein. Toxins, 9, Article No. 136. [Google Scholar] [CrossRef] [PubMed]
[13] Chen, D., Li, C., Zhao, Y., Zhou, J., Wang, Q. and Xie, Y. (2021) Bioinformatics Analysis for the Identification of Differentially Expressed Genes and Related Signaling Pathways in H. pylori-CagA Transfected Gastric Cancer Cells. PeerJ, 9, e11203. [Google Scholar] [CrossRef] [PubMed]
[14] Xu, W., Xu, L. and Xu, C. (2022) Relationship between Helicobacter pylori Infection and Gastrointestinal Microecology. Frontiers in Cellular and Infection Microbiology, 12, Article ID: 938608. [Google Scholar] [CrossRef] [PubMed]
[15] Zavros, Y. and Merchant, J.L. (2022) The Immune Microenvironment in Gastric Adenocarcinoma. Nature Reviews Gastroenterology & Hepatology, 19, 451-467. [Google Scholar] [CrossRef] [PubMed]
[16] Li, X., Sun, X., Kan, C., Chen, B., Qu, N., Hou, N., et al. (2022) COL1A1: A Novel Oncogenic Gene and Therapeutic Target in Malignancies. PathologyResearch and Practice, 236, Article ID: 154013. [Google Scholar] [CrossRef] [PubMed]
[17] Van Doren, S.R. (2015) Matrix Metalloproteinase Interactions with Collagen and Elastin. Matrix Biology, 44, 224-231. [Google Scholar] [CrossRef] [PubMed]
[18] Guo, Y., Lu, G., Mao, H., Zhou, S., Tong, X., Wu, J., et al. (2020) miR-133b Suppresses Invasion and Migration of Gastric Cancer Cells via the COL1A1/TGF-β Axis. OncoTargets and Therapy, 13, 7985-7995. [Google Scholar] [CrossRef] [PubMed]
[19] Wang, Q. and Yu, J. (2018) miR-129-5p Suppresses Gastric Cancer Cell Invasion and Proliferation by Inhibiting COL1A1. Biochemistry and Cell Biology, 96, 19-25. [Google Scholar] [CrossRef] [PubMed]